First Page | Document Content | |
---|---|---|
Date: 2013-05-28 10:53:48Clinical pharmacology Food and Drug Administration Therapeutics United States Public Health Service Zalcitabine Didanosine Pharmaceutical sciences Medicine Pharmacology | Microsoft Word[removed]Drug and Device Committee Final ReportAdd to Reading ListSource URL: www.afdo.orgDownload Document from Source WebsiteFile Size: 145,92 KBShare Document on Facebook |